Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer

Human epidermal growth factor receptor 2 (HER2)-amplified breast cancers are treated using targeted antibodies and kinase inhibitors, but resistance to these therapies leads to systemic tumor recurrence of metastatic disease. Herein, we conducted gene expression analyses of HER2 kinase inhibitor-res...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncogene
Главные авторы: Abdullah, Ammara, Akhand, Saeed Salehin, Paez, Juan Sebastian Paez, Brown, Wells, Pan, Li, Libring, Sarah, Badamy, Michael, Dykuizen, Emily, Solorio, Luis, Andy Tao, W., Wendt, Michael K.
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7808937/
https://ncbi.nlm.nih.gov/pubmed/33128042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01530-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы